Table 5.
Array 1 | Array 2 | Array 1 and Array 2 | |
---|---|---|---|
Spot # | Spot to Spot CV | Spot to Spot CV | Well to Well CV |
1 Control | 8% | 9% | 6% |
2 Control | 19% | 23% | 13% |
3 Control | 14% | 14% | 12% |
4 Control | 15% | 21% | 13% |
5 PARK7 | 15% | 22% | 14% |
6 CCNA2 | 14% | 14% | 15% |
7 ACID2 | 15% | 14% | 14% |
8 CALD1 | 13% | 16% | 17% |
9 CHD-3 | 16% | 20% | 11% |
10 DBN1 | 20% | 18% | 14% |
11 GAPDHS | 16% | 21% | 12% |
12 HSF4 | 17% | 21% | 16% |
13 KLK3 | 14% | 17% | 13% |
14 NFAT1 | 16% | 18% | 15% |
15 PEX10 | 14% | 15% | 14% |
16 SOS1 | 13% | 16% | 14% |
17 STAT2 | 11% | 19% | 16% |
18 STX6 | 20% | 25% | 21% |
19 TARDBP | 21% | 21% | 13% |
20 TLN1 | 15% | 17% | 12% |
21 AR | 16% | 18% | 13% |
22 b-Tubulin | 10% | 13% | 10% |
23 CASP8 | 14% | 16% | 13% |
24 Cyclin D1 | 12% | 16% | 12% |
25 HSPA1A/B | 15% | 18% | 12% |
26 p53 | 13% | 19% | 16% |
27 p73 | 16% | 21% | 17% |
28 LEDGF/PSIP1 |
15% | 19% | 18% |
29 PTEN | 30% | 28% | 16% |
30 PXN | 23% | 24% | 16% |
31 TOP1 | 13% | 14% | 10% |
Averages | 16% | 18% | 14% |